Who We are
Impartiality, ethics, transparency, technical excellence and quality. These are the values which guide the activities of MAGABI Pesquisas Clínicas e Farmacêuticas Ltda since its creation, on December, 2005, setting its headquarters in Interlagos, a neighborhood from São Paulo. At the time, the Brazilian market lacked specialized laboratories to analyze biological samples taken from Bioequivalence or Relative Bioavailability studies, while the demand for this type of service was being leveraged by the enactment of Law 9787/1999, which established the rules for registration of generic drugs in Brazil and made such tests mandatory.
Driven by this scenario, MAGABI began developing in Brazil a work which, by that time, was only carried out abroad, thus becoming the first laboratory in the country to analyze biological samples for a bioequivalence study of oral contraceptive (hormone).
The commitment to innovation and the pioneering spirit are still present in all bioanalytical services performed by MAGABI since 2006, the year when they attained their first primary certification in Good Practices in Bioequivalence/Relative Bioavailability upon the National Health Surveillance Agency (Anvisa).
MAGABI has already carried out Bioequivalence and Relative Bioavailability studies for companies placed in Brazil, Chile, Uruguay and Colombia.